Evolus Company Insiders

EOLS Stock  USD 13.97  0.24  1.69%   
Evolus' insiders are aggressively selling. The analysis of insiders' sentiment of trading Evolus Inc stock suggests that vertually all insiders are panicking at this time. Evolus employs about 322 people. The company is managed by 10 executives with a total tenure of roughly 20 years, averaging almost 2.0 years of service per executive, having 32.2 employees per reported executive.
David Moatazedi  CEO
President CEO, Director
Crystal Muilenburg  President
Vice President Corporate Communications and Public Relations

Evolus' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-12-23Sandra BeaverDisposed 1586 @ 10.85View
2024-09-06Sandra BeaverDisposed 3276 @ 14.98View
2024-08-30Tomoko Yamagishi-DresslerDisposed 5631 @ 15.85View
2024-06-05David MoatazediDisposed 155278 @ 12.92View
2024-06-03Vikram MalikDisposed 7500 @ 12.96View
2024-05-13David N GillDisposed 3643 @ 12.72View
2024-05-10Sandra BeaverDisposed 2423 @ 12.72View
2024-03-27David MoatazediDisposed 6236 @ 13.86View
2024-03-19Rui AvelarDisposed 27603 @ 13.92View
2024-02-22Sandra BeaverDisposed 1821 @ 13.08View
Monitoring Evolus' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Evolus' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Evolus' future performance. Based on our forecasts, it is anticipated that Evolus will maintain a workforce of slightly above 320 employees by March 2025.
 
Covid

Evolus Management Team Effectiveness

The company has return on total asset (ROA) of (0.0993) % which means that it has lost $0.0993 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.6168) %, meaning that it created substantial loss on money invested by shareholders. Evolus' management efficiency ratios could be used to measure how well Evolus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 2.82 in 2025, whereas Return On Tangible Assets are likely to drop (0.48) in 2025. At this time, Evolus' Intangible Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.57 in 2025, whereas Net Tangible Assets are likely to drop (62 M) in 2025.
Common Stock Shares Outstanding is likely to drop to about 37.9 M in 2025. Net Loss is likely to drop to about (70.3 M) in 2025

Evolus Workforce Comparison

Evolus Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 17,408. Evolus claims roughly 322 in number of employees contributing just under 2% to equities under Health Care industry.

Evolus Profit Margins

The company has Profit Margin (PM) of (0.22) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.21.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.740.8
Significantly Down
Slightly volatile

Evolus Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Evolus insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.5
1
2
 23,014 
 8,907 
2024-06-01
0.1667
2
12
 331,218 
 870,426 
2024-03-01
3.375
27
8
 904,307 
 159,356 
2023-09-01
2.75
11
4
 591,924 
 22,378 
2023-03-01
3.3333
20
6
 917,134 
 4,159,781 
2022-09-01
1.75
7
4
 86,410 
 143,700 
2022-03-01
4.2
21
5
 1,176,009 
 70,955 
2021-09-01
1.5
18
12
 799,461 
 2,898,631 
2021-03-01
1.625
13
8
 694,409 
 72,407 
2020-03-01
5.3333
16
3
 624,644 
 8,701,788 
2019-12-01
1.0
1
1
 10,020 
 10,020 
2019-06-01
0.8333
5
6
 1,971,889 
 7,907,954 
2018-12-01
6.0
6
1
 328,171 
 573,888 
2018-09-01
1.5
3
2
 22,960 
 2,750,000 
2018-06-01
18.0
18
1
 1,675,985 
 0.00 
2018-03-01
0.0833
1
12
 2,065,875 
 3,438,442 

Evolus Notable Stakeholders

An Evolus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Evolus often face trade-offs trying to please all of them. Evolus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Evolus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David MoatazediPresident CEO, DirectorProfile
Crystal MuilenburgVice President Corporate Communications and Public RelationsProfile
Kurt KnabVice President of SalesProfile
Jessica NovakSenior ResourcesProfile
Tomoko YamagishiDresslerChief OfficerProfile
CCFP DipSportMedChief RDProfile
David EricksonVP RelationsProfile
Sandra BeaverChief OfficerProfile
Jeffrey PlumerGeneral CounselProfile
Nareg SagherianHead CommunicationsProfile

About Evolus Management Performance

The success or failure of an entity such as Evolus Inc often depends on how effective the management is. Evolus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Evolus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Evolus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.46)(0.48)
Return On Capital Employed(0.31)(0.33)
Return On Assets(0.38)(0.39)
Return On Equity 2.68  2.82 
Please note, the imprecision that can be found in Evolus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evolus Inc. Check Evolus' Beneish M Score to see the likelihood of Evolus' management manipulating its earnings.

Evolus Workforce Analysis

Traditionally, organizations such as Evolus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Evolus within its industry.

Evolus Manpower Efficiency

Return on Evolus Manpower

Revenue Per Employee627.6K
Revenue Per Executive20.2M
Net Loss Per Employee191.6K
Net Loss Per Executive6.2M
Working Capital Per Employee199.2K
Working Capital Per Executive6.4M

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.